In addition to adverse cardiovascular effects of class II beta-adrenergic blockers, other adverse effects include:

• CNS—insomnia, syncope, mental depression, emotional lability, fatigue, headache, dizziness, lethargy, vivid dreams, hallucinations, light-headedness
• Respiratory—dyspnea, bronchospasm, especially in patients with asthma or other bronchospastic disease.